Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce7c542a5a6dc02c10fc2e0a619c4186 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2013-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7383b519e025d6d66bc1b30eb9dd1ab5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c361e1274eb488e74a53f35903c45208 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4af0bcc19d84388f9532233ba619b78e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cf75bc94d9c7bc6875859f7838bb174 |
publicationDate |
2015-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2015197812-A1 |
titleOfInvention |
CIRCULATING miRNAs AS MARKERS FOR BREAST CANCER |
abstract |
The present invention is directed to methods for diagnosing breast cancer, metastasizing breast cancer, or for determining the CTC status in a subject. Moreover, the present invention is concerned with devices and kits for carrying methods of the invention. The methods comprise determining in a sample of a subject suspected to be afflicted with breast cancer the amount of at least one miRNA selected from a recited list of miRNAs, followed by comparing the amount with one or more references, whereby breast cancer is to be diagnosed. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10941451-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11535895-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018245159-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111154878-A |
priorityDate |
2012-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |